| Literature DB >> 14708711 |
Valeska Hofmeister1, Elisabeth H Weiss.
Abstract
HLA-G regulates immune responses as it binds different receptors expressed on natural killer (NK) cells, T cells and myeloid cells. HLA-G1 can inhibit NK- and T-cell-mediated lysis of target cells by its interaction with the inhibitory receptors ILT2 and ILT4. Engaging KIR2DL4 triggers different reactions depending on the activation state of the effector cells. The indirect recognition of HLA-G as peptide presented by HLA-E and recognized by the CD94/NKG2 receptor family might further power the battle between the immune system and tumor cells. Secreted HLA-G5 can also bind CD8 and induces Fas/Fas ligand-mediated apoptosis in activated CD8+ lymphocytes.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14708711 DOI: 10.1016/s1044-579x(03)00022-1
Source DB: PubMed Journal: Semin Cancer Biol ISSN: 1044-579X Impact factor: 15.707